← Browse by Condition
Medical Condition
hereditary angioedema
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 3
NCT06806657 Phase 4
Recruiting
Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab
Enrollment
30 pts
Location
United States, Canad...
Sponsor
CSL Behring
NCT06960213 Phase 3
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Enrollment
90 pts
Location
United States, Canad...
Sponsor
ADARx Pharmaceuticals, Inc.
NCT06573723
Recruiting
Institutional Registry of Rare Diseases
Enrollment
380 pts
Location
Argentina
Sponsor
Hospital Italiano de Buenos Ai...